Injectable Drug Delivery Market

Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Ask The Analyst Customization Available Request Methodology

Introduction

Drug delivery refers to the approaches, technologies and systems used for the administration of drugs to patients. Injectable drug delivery refers to the approach of administering the drug by penetration of needle or similar device into the skin. The administration may be either intravenous, sub-cutaneous or intra muscular based on the region of administration of the drug. The injectable drug delivery products can be categorized based on types as self-injectors, needle-free injectors and auto-injectors.

Self-injectors type of injectable drug delivery include wearable injectors that are small and handy. Self-injectors injectable drug delivery devices have a fine needle, which helps to reduce pain, and are generally used when a drug needs to be administered continuously, e.g., in the case of continuous administration and monitoring of insulin in patients suffering from diabetes. These devices either adhered to the skin or come with a belt. Needle-free type of injectable drug delivery are devices that allow the administration of drugs without the use of needles, but have similar administration that of a syringe. These injectable drug delivery devices may be pre-filled or fillable. Whereas the auto-injector type of injectable drug delivery are automated mechanical syringes, which may have selection of volume as an added feature. These devices are generally prefilled and disposable.

The growing competition in the emerging regions and rising demand for injectable drug delivery are some of the major factors expected to drive the growth of the injectable drug delivery market during the forecast period. For instance, pharmaceutical companies that have expanded in the Asia Pacific countries, such as China, are trying compete with Mylan for EpiPen. Similarly, patients suffering with conditions such as dementia and rheumatoid arthritis find it difficult to use conventional injections. The auto-injectors and other injectable drug delivery devices are easy to use and they help in reducing pain, which is the prime factor expected to increase the demand for injectable drug delivery devices.

Market Value and Forecast

FMI estimates that the global market for injectable drug delivery is expected to surpass US$ 32,136.9 Mn by 2028 end, expanding at a CAGR of 10.9% over 2018–2028. The needle-free type of injectable drug delivery is expected to be the dominant product type segment in the global injectable drug delivery market, which accounted about 40% revenue share in 2017, due to a large pool of patients suffering from diabetes, who generally prefer needle-free type of injectable drug delivery devices for a pain-free experience. Although North America is expected to be the dominant regional market for injectable drug delivery, Asia Pacific and Middle East & Africa injectable drug delivery market is expected to expand at high CAGRs over the forecast period.

Market Dynamics

The global injectable drug delivery market is expected to be driven by increasing prevalence of chronic diseases such as diabetes and cancer. According to the WHO, cancer is the leading cause of deaths across the globe. In 2015, cancer was responsible for nearly 8.8 million deaths worldwide. According to the National Cancer Institute, an estimated 1,735,350 new cases of cancer are expected to be diagnosed in the U.S. in 2018. Furthermore, most of the injectable drug delivery devices find wide application in the treatment of diabetes. Since diabetic patients are prescribed with insulin, they require regular injection of insulin. However, the risk of needle stick injuries is a growing concern. Thus, wearable insulin pumps and other injectable drug delivery devices are the preferred option for diabetic patients, since these devices have fine needles, which reduce the likelihood of injuries.

Injectable-Drug-Delivery-Market.jpg

Key Regions

The global market for injectable drug delivery is segmented in to seven key regions viz. North America, Eastern Europe, Western Europe, Latin America, Asia Pacific except Japan (APEJ), Japan and the Middle East and Africa (MEA). North America injectable drug delivery market accounted a significant share of the global market in 2017, followed by Western Europe and Asia Pacific. The North America & Western Europe injectable drug delivery market is foreseen to lose its share to Asia Pacific, partly due to growing adoption and expansion of current manufacturers of injectable drug delivery. Thus, the injectable drug delivery market in Asia Pacific is expected to have strong growth during the forecast period. Furthermore, China, being one of the most populated regions in the world, has high aged population and the number is growing steadily. The increasing ageing population in the region is consequently expected to drive the growth of the injectable drug delivery market in the Asia Pacific region.

Key Players

The key players identified in the global injectable drug delivery market can be classified based on the type of product they offer. Examples of some the key players manufacturing self-injector type of injectable drug delivery are Amgen, Medtronic Plc, Dexcom, West Pharmaceutical Services, and Consort Medical (Bespak), among others. The key players manufacturing needle-free type of injectable drug delivery are Crossject, Endo International Plc, and Penjet Corporation, among others. The key players manufacturing auto-injector type of injectable drug delivery are Amgen, Antares Pharma, Becton, and Dickinson and Company, Mylan, and SHL Group, among others.

Report Description

This Future Market Insights (FMI) report examines the global injectable drug delivery market for the period 2018–2028. The primary objective of the report is to offer insights into market opportunity for the injectable drug delivery market.

The global injectable drug delivery market has seen substantial growth in the last decade. The market for injectable drug delivery is primarily driven by increasing prevalence of chronic diseases such as cancer, rheumatoid arthritis and diabetes. Other factors that drive the growth of the injectable drug delivery market include the need for patient-controlled delivery platforms and significant advancement in the technology. Increase in demand for point-of-care devices and the reduced dependence on healthcare provision are the other factors contributing to the growth of the injectable drug delivery market. However, stringent regulatory framework and high likelihood of premium pricing are some of the prime barriers in the growth of the injectable drug delivery market.

The Global Injectable Drug Delivery Market has been Segmented Based on:

  • Product Type

  • Usage

  • Distribution Channel

  • Regions

The report analyses the global injectable drug delivery market in terms of value. The global injectable drug delivery market report begins with the injectable drug delivery market definition and explaining different products and technologies. The injectable drug delivery market view point section includes FMI’s analysis on key trends, drivers, restraints, opportunities, trends and macro factors influencing the global injectable drug delivery market. Some of the key inclusions of injectable drug delivery report are key manufacturers and their key developments, epidemiology data and PEST analysis.

The report analyses the injectable drug delivery market based on regions and presents the forecast in terms of value for the next 10 years. The regions covered in the report include:

  • North America

  • Eastern Europe

  • Western Europe

  • Latin America

  • Asia Pacific except Japan (APEJ)

  • Japan

  • Middle East and Africa (MEA)

Each of these sections analyse the regional injectable drug delivery market by product type, usage, distribution channel and country. The regional introductory section provides a snapshot of the regional and segmental injectable drug delivery market shares. The intensity map of the drivers and restrains in every region helps to analyse the effective regional drivers for the injectable drug delivery market.

When developing the injectable drug delivery market forecast, the starting point is sizing the current market, which forms the base for the forecast of how the injectable drug delivery market is expected to take shape in the near future. To arrive at the current market size, we have used company share analysis for the majority of the companies. The company share analysis was executed for each of the product types separately in order to arrive at the total market value. The analysis was further broken down to country level to arrive at the total regional market size of injectable drug delivery. Given the characteristics of injectable drug delivery market, we have triangulated the outcome based on different analysis based on supply side, demand side and GDP growth rate. However, quantifying the injectable drug delivery market across aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities, rather than rationalizing them after the forecast has been completed.

The following parameters are used to estimate the injectable drug delivery market size for the base year 2017:

  • Country level data for GDP and health care spending

  • Epidemiology of main indications of injectable drug delivery

  • Regional trends and opportunities

The forecast presented in the global injectable drug delivery market report provides total revenue of injectable drug delivery over 2018–2028. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. The market structure analysis provides tier-wise breakdown of total market revenue. The section also provides company share analysis for self-injectors market and the auto-injectors market separately. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to the market segments. Detailed profiles of players in the injectable drug delivery market are also provided in the report, which highlight company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of the global injectable drug delivery market report analyses the injectable drug delivery market based on product type and presents the forecast in terms of value for the next 10 years. The injectable drug delivery types covered in the report include:

  • Self-Injectors

  • Needle-free Injectors

  • Auto-Injectors

The next section of report analyses the market based on usage of injectable drug delivery products and provides forecast in terms of value for the next 10 years. The usages covered in this report include:

  • Disposable Injectors

  • Reusable Injectors

The next section of report analyses the market based on distribution channel of injectable drug delivery products and provides forecast in terms of value for the next 10 years. The distribution channels covered in this report include:

  • Hospital Pharmacies

  • Retail Pharmacies

  • E-commerce

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the products. To understand the key growth segments, Future Market Insights provides the ‘Attractiveness Index’ analysis, which helps to identify real market opportunities.

Injectable Drug Delivery Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Injectable Drug Delivery Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Market Background

4.1. Recent Developments

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

5. Global Economic Outlook

5.1. Gross Domestic Product by Region & Country, 2006 – 2021

6. Key Inclusions

6.1. Key Manufacturer List

6.2. Key Developments

6.3. PEST Analysis

7. North America Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

7.1. Introduction

7.2. Regional Market Trends

7.3. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017

7.3.1. U.S.

7.3.2. Canada

7.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

7.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

7.5.1. Self-Injectors

7.5.2. Needle free Injectors

7.5.2.1. Pre Filled Needle free injectors

7.5.2.2. Fill-Able Needle Free Injectors

7.5.3. Auto Injectors

7.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

7.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

7.7.2. Reusable Injectors

7.7.2. Reusable Injectors

7.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

7.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

7.9.1. Retail Pharmacies

7.9.2. Hospital pharmacies

7.9.3. E-Commerce

7.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

7.11.Drivers and Restraints: Impact Analysis

7.12.Market Attractiveness Analysis

7.12.1. By Country

7.12.2. By Product

7.12.3. By Usage

7.12.4. By Distribution Channel

7.13.Drivers and Restraints – Impact Analysis

8. Eastern Europe Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

8.1. Introduction

8.2. Regional Market Trends

8.3. Historical Market Size (US$ Mn) By Country, 2013–2017

8.3.1. Germany

8.3.2. France

8.3.3. U.K.

8.3.4. Spain

8.3.5. Italy

8.3.6. Rest of Western Europe

8.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

8.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

8.5.1. Self-Injectors

8.5.2. Needle free Injectors

8.5.2.1. Pre Filled Needle free injectors

8.5.2.2. Fill-Able Needle Free Injectors

8.5.3. Auto Injectors

8.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

8.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

8.7.1. Disposable Injectors

8.7.2. Reusable Injectors

8.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

8.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

8.9.1. Retail Pharmacies

8.9.2. Hospital pharmacies

8.9.3. E-Commerce

8.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

8.11.Drivers and Restraints: Impact Analysis

8.12.Market Attractiveness Analysis

8.12.1. By Country

8.12.2. By Product

8.12.3. By Usage

8.12.4. By Distribution Channel

8.13. Drivers and Restraints – Impact Analysis

9. Western Europe Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

9.1. Introduction

9.2. Regional Market Trends

9.3. Historical Market Size (US$ Mn) By Country, 2013–2017

9.3.1. Russia

9.3.2. Poland

9.3.3. Rest of Eastern Europe

9.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

9.5.1. Self-Injectors

9.5.2. Needle free Injectors

9.5.2.1. Pre Filled Needle free injectors

9.5.2.2. Fill-Able Needle Free Injectors

9.5.3. Auto Injectors

9.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

9.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

9.7.1. Disposable Injectors

9.7.2. Reusable Injectors

9.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

9.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

9.9.1. Retail Pharmacies

9.9.2. Hospital pharmacies

9.9.3. E-Commerce

9.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

9.11.Drivers and Restraints: Impact Analysis

9.12. Market Attractiveness Analysis

9.12.1. By Country

9.12.2. By Product

9.12.3. By Usage

9.12.4. By Distribution Channel

9.13. Drivers and Restraints – Impact Analysis

10. Latin America Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

10.1. Introduction

10.2. Regional Market Trends

10.3. Historical Market Size (US$ Mn) By Country, 2013–2017

10.3.1. Brazil

10.3.2. Mexico

10.3.3. Rest of Latin America

10.4.Market Size (US$ Mn) Forecast By Country, 2018–2028

10.5.Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

10.5.1. Self-Injectors

10.5.2. Needle free Injectors

10.5.2.1. Pre Filled Needle free injectors

10.5.2.2. Fill-Able Needle Free Injectors

10.5.3. Auto Injectors

10.6.Market Size (US$ Mn) Forecast By Product Type, 2018–2028

10.7.Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

10.7.1. Disposable Injectors

10.7.2. Reusable Injectors

10.8.Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

10.9.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

10.9.1. Retail Pharmacies

10.9.2. Hospital pharmacies

10.9.3. E-Commerce

10.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

10.11. Drivers and Restraints: Impact Analysis

10.12. Market Attractiveness Analysis

10.12.1. By Country

10.12.2. By Product

10.12.3. By Usage

10.12.4. By Distribution Channel

10.13. Drivers and Restraints – Impact Analysis

11. Asia Pacific excluding Japan and China (APEJC) Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

11.1. Introduction

11.2. Regional Market Trends

11.3. Historical Market Size (US$ Mn) By Country, 2013–2017

11.3.1. India

11.3.2. Australia and New Zealand

11.3.3. China

11.3.4. ASEAN

11.3.5. Rest of APEJ

11.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

11.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

11.5.1. Self-Injectors

11.5.2. Needle free Injectors

11.5.2.1. Pre Filled Needle free injectors

11.5.2.2. Fill-Able Needle Free Injectors

11.5.3. Auto Injectors

11.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

11.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

11.7.1. Disposable Injectors

11.7.2. Reusable Injectors

11.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

11.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

11.9.1. Retail Pharmacies

11.9.2. Hospital pharmacies

11.9.3. E-Commerce

11.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

11.11. Drivers and Restraints: Impact Analysis

11.12. Market Attractiveness Analysis

11.12.1. By Country

11.12.2. By Product

11.12.3. By Usage

11.12.4. By Distribution Channel

11.13. Drivers and Restraints – Impact Analysis

12. Japan Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

12.1. Introduction

12.2. Market Trends

12.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

12.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

12.5.1. Self-Injectors

12.5.2. Needle free Injectors

12.5.2.1. Pre Filled Needle free injectors

12.5.2.2. Fill-Able Needle Free Injectors

12.5.3. Auto Injectors

12.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

12.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

12.7.1. Disposable Injectors

12.7.2. Reusable Injectors

12.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

12.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

12.9.1. Retail Pharmacies

12.9.2. Hospital pharmacies

12.9.3. E-Commerce

12.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

12.11. Drivers and Restraints: Impact Analysis

12.12. Market Attractiveness Analysis

12.12.1. By Product

12.12.2. By Usage

12.12.3. By Distribution Channel

12.13. Drivers and Restraints – Impact Analysis

13. MEA Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

13.1. Introduction

13.2. Regional Market Trends

13.3. Historical Market Size (US$ Mn) By Country, 2013–2017

13.3.1. GCC Countries

13.3.2. South Africa

13.3.3. Rest of MEA

13.4. Market Size (US$ Mn) Forecast By Country, 2018–2028

13.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

13.5.1. Self-Injectors

13.5.2. Needle free Injectors

13.5.2.1. Pre Filled Needle free injectors

13.5.2.2. Fill-Able Needle Free Injectors

13.5.3. Auto Injectors

13.6. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

13.7. Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

13.7.1. Disposable Injectors

13.7.2. Reusable Injectors

13.8. Market Size (US$ Mn) Forecast By Usage Type, 2018–2028

13.9.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

13.9.1. Retail Pharmacies

13.9.2. Hospital pharmacies

13.9.3. E-Commerce

13.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

13.11. Drivers and Restraints: Impact Analysis

13.12. Market Attractiveness Analysis

13.12.1. By Country

13.12.2. By Product

13.12.3. By Usage

13.12.4. By Distribution Channel

13.13. Drivers and Restraints – Impact Analysis

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Competition Analysis

16.1. Competition Dashboard

16.2. Market Share & Structure Analysis

16.3. Company Deep Dive

16.3.1. Amgen Inc.

16.3.1.1. Overview

16.3.1.2. Product and Usage Portfolio

16.3.1.3. Production Footprint

16.3.1.4. Sales Footprint

16.3.1.5. Channel Footprint

16.3.1.6. Strategy

16.3.1.6.1. Marketing Strategy

16.3.1.6.2. Product Strategy

16.3.1.6.3. Channel Strategy

16.3.2. Antares Pharma Inc.

16.3.2.1. Overview

16.3.2.2. Product and Usage Portfolio

16.3.2.3. Production Footprint

16.3.2.4. Sales Footprint

16.3.2.5. Channel Footprint

16.3.2.6. Strategy

16.3.2.6.1. Marketing Strategy

16.3.2.6.2. Product Strategy

16.3.2.6.3. Channel Strategy

16.3.3. Becton, Dickinson and Company

16.3.3.1. Overview

16.3.3.2. Product and Usage Portfolio

16.3.3.3. Production Footprint

16.3.3.4. Sales Footprint

16.3.3.5. Channel Footprint

16.3.3.6. Strategy

16.3.3.6.1. Marketing Strategy

16.3.3.6.2. Product Strategy

16.3.3.6.3. Channel Strategy

16.3.4. Consort Medical Plc (Bespak)

16.3.4.1. Overview

16.3.4.2. Product and Usage Portfolio

16.3.4.3. Production Footprint

16.3.4.4. Sales Footprint

16.3.4.5. Channel Footprint

16.3.4.6. Strategy

16.3.4.6.1. Marketing Strategy

16.3.4.6.2. Product Strategy

16.3.4.6.3. Channel Strategy

16.3.5. Crossjet

16.3.5.1. Overview

16.3.5.2. Product and Usage Portfolio

16.3.5.3. Production Footprint

16.3.5.4. Sales Footprint

16.3.5.5. Channel Footprint

16.3.5.6. Strategy

16.3.5.6.1. Marketing Strategy

16.3.5.6.2. Product Strategy

16.3.5.6.3. Channel Strategy

16.3.6. Medtronic plc

16.3.6. Overview

16.3.6.2. Product and Usage Portfolio

16.3.6.3. Production Footprint

16.3.6.4. Sales Footprint

16.3.6.5. Channel Footprint

16.3.6.6. Strategy

16.3.6.6.1. Marketing Strategy

16.3.6.6.2. Product Strategy

16.3.6.6.3. Channel Strategy

16.3.7. Mylan N.V.

16.3.7.1. Overview

16.3.7.2. Product and Usage Portfolio

16.3.7.3. Production Footprint

16.3.7.4. Sales Footprint

16.3.7.5. Channel Footprint

16.3.7.6. Strategy

16.3.7.6.1. Marketing Strategy

16.3.7.6.2. Product Strategy

16.3.7.6.3. Channel Strategy

16.3.8. SHL Group

16.3.8.1. Overview

16.3.8.2. Product and Usage Portfolio

16.3.8.3. Production Footprint

16.3.8.4. Sales Footprint

16.3.8.5. Channel Footprint

16.3.8.6. Strategy

16.3.8.6.1. Marketing Strategy

16.3.8.6.2. Product Strategy

16.3.8.6.3. Channel Strategy

16.3.9. West Pharmaceutical Services

16.3.9.1. Overview

16.3.9.2. Product and Usage Portfolio

16.3.9.3. Production Footprint

16.3.9.4. Sales Footprint

16.3.9.5. Channel Footprint

16.3.9.6. Strategy

16.3.9.6.1. Marketing Strategy

16.3.9.6.2. Product Strategy

16.3.9.6.3. Channel Strategy

16.3.10. Ypsomed

16.3.10.1. Overview

16.3.10.2. Product and Usage Portfolio

16.3.10.3. Production Footprint

16.3.10.4. Sales Footprint

16.3.10.5. Channel Footprint

16.3.10.6. Strategy

16.3.10.6.1. Marketing Strategy

16.3.10.6.2. Product Strategy

16.3.10.6.3. Channel Strategy

17. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Region

17.1.Introduction / Key Findings

17.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017

17.2.1. North America

17.2.2. Western Europe

17.2.3. Eastern Europe

17.2.4. Latin America

17.2.5. Asia Pacific excluding Japan

17.2.6. Japan

17.2.7. Middle East and Africa

17.3. Market Size (US$ Mn) Forecast By Region, 2018–2028

17.4.Market Attractiveness Analysis By Region

18. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Product

18.1. Introduction

18.2.Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017

18.2.1. Self-Injectors

18.2.2. Needle-free Injectors

18.2.3. Auto-Injectors

18.3. Market Size (US$ Mn) Forecast By Product Type, 2018–2028

18.4.Market Attractiveness Analysis By Product Type

19. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Usage

19.1. Introduction

19.2.Historical Market Size (US$ Mn) Trend Analysis By Usage, 2013–2017

19.2.1. Disposable Injectors

19.2.2. Reusable Injectors

19.3. Market Size (US$ Mn) Forecast By Usage, 2018–2028

19.4.Market Attractiveness Analysis By Usage

20. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

20.1. Introduction

20.2.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

20.2.1. Retail Pharmacies

20.2.2. Hospital Pharmacies

20.2.3. E-commerce

20.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

20.4.Market Attractiveness Analysis By Distribution Channel

21. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

21.1.Market Value Share Analysis

21.1.1. By Country

21.1.2. By Product

21.1.3. By Usage

21.1.5. By Distribution Channel

21.2.Y-o-Y Growth Analysis

21.2.1. By Country

21.2.2. By Product

21.2.3. By Usage

21.2.5. By Distribution Channel

21.3. Absolute $ Opportunity

Injectable Drug Delivery Market Reports - List of Tables

Table 01: Global Manufacturers of Injectable Drug Delivery Market

Table 02: Global Manufacturers of Injectable Drug Delivery Market

Table 03: North America Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 04: North America Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

Table 05: North America Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Usage

Table 06: North America Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel

Table 07: Eastern Europe Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 08: Eastern Europe Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

Table 09: Eastern Europe Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Usage

Table 10: Eastern Europe Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel

Table 11: Western Europe Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 12: Western Europe Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

Table 13: Western Europe Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Usage

Table 14: Western Europe Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel

Table 15: Latin America Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 16: Latin America Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

Table 17: Latin America Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Usage

Table 18: Latin America Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel

Table 19: APEJ Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 20: APEJ Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

Table 21: APEJ Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Usage

Table 22: APEJ Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel

Table 23: Japan Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

Table 24: Japan Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Usage

Table 25: Japan Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel

Table 26: MEA Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country

Table 27: MEA Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

Table 28: MEA Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Usage

Table 29: MEA Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel

Table 30: Global Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Region

Table 31: Global Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Product Type

Table 32: MEA Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Usage

Table 33: Global Injectable Drug Delivery Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel

Injectable Drug Delivery Market Reports - List of Figures

Figure 01: Global Injectable Drug Delivery Market Share by Product Type (2017A)

Figure 02: Global Injectable Drug Delivery Market Share by Usage (2017A)

Figure 03: Global Injectable Drug Delivery Market Share by Distribution Channel (2017A)

Figure 04: Global Injectable Drug Delivery Market Share by Region (2017A)

Figure 05: Global Healthcare Expenditure in US$ Mn (2013–2020)

Figure 06: North America Injectable Drug Delivery Market Size

Figure 07: North America Injectable Drug Delivery Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 08: U.S. Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 09: U.S. Ambulance Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 10: Canada Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 11: Canada Injectable Drug Delivery Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 12: North America Self-injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 13: North America Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 14: North America Needle-free Injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 15: North America Needle-free Injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 16: North America Auto injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 17: North America Auto injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 18: North America Injectable Drug Delivery Market Attractiveness Analysis, By Country

Figure 19: North America Injectable Drug Delivery Market Attractiveness Analysis, By Product Type

Figure 20: North America Injectable Drug Delivery Market Attractiveness Analysis, By Usage

Figure 21: North America Injectable Drug Delivery Market Attractiveness Analysis, By Distribution Channel

Figure 22: Eastern Europe Injectable Drug Delivery Market Size

Figure 23: Eastern Europe Injectable Drug Delivery Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 24: Russia Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 25: Russia Ambulance Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 26: Poland Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 27: Poland Injectable Drug Delivery Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 28: Rest of Eastern Europe Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 29: Rest of Eastern Europe Ambulance Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 30: Eastern Europe Self-injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 31: Eastern Europe Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 32: Eastern Europe Needle-free Injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 33: Eastern Europe Needle-free Injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 34: Eastern Europe Autoinjectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 35: Eastern Europe Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 36: Eastern Europe Injectable Drug Delivery Market Attractiveness Analysis, By Country

Figure 37: Eastern Europe Injectable Drug Delivery Market Attractiveness Analysis, By Product Type

Figure 38: Eastern Europe Injectable Drug Delivery Market Attractiveness Analysis, By Usage

Figure 39: Eastern Europe Injectable Drug Delivery Market Attractiveness Analysis, By Distribution Channel

Figure 40: Western Europe Injectable Drug Delivery Market Size

Figure 41: Western Europe Injectable Drug Delivery Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 42: Germany Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 43: Germany Ambulance Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 44: U.K. Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 45: U.K. Injectable Drug Delivery Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 46: France Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 47: France Ambulance Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 48: Italy Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 49: Italy Injectable Drug Delivery Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 50: Spain Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 51: Spain Ambulance Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 52: Rest of Western Europe Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 53: Rest of Western Europe Injectable Drug Delivery Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 54: Western Europe Self-injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 55: Western Europe Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 56: Western Europe Needle-free Market Size (US$ Mn) Analysis, 2013–2017

Figure 57: Western Europe Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 58: Western Europe Autoinjectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 59: Western Europe Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 60: Western Europe Injectable Drug Delivery Market Attractiveness Analysis, By Country

Figure 61: Western Europe Injectable Drug Delivery Market Attractiveness Analysis, By Product Type

Figure 62: Western Europe Injectable Drug Delivery Market Attractiveness Analysis, By Usage

Figure 63: Western Europe Injectable Drug Delivery Market Attractiveness Analysis, By Distribution Channel

Figure 64: Latin America Injectable Drug Delivery Market Size

Figure 65: Latin America Injectable Drug Delivery Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 66: Brazil Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 67: Brazil Ambulance Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 68: Mexico Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 69: Mexico Injectable Drug Delivery Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 70: Rest of Latin America Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 71: Rest of Latin America Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 72: Latin America Self-injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 73: Latin America Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 74: Latin America Needle-free Market Size (US$ Mn) Analysis, 2013–2017

Figure 75: Latin America Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 76: Latin America Autoinjectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 77: Latin America Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 78: Latin America Injectable Drug Delivery Market Attractiveness Analysis, By Country

Figure 79: Latin America Injectable Drug Delivery Market Attractiveness Analysis, By Product Type

Figure 80: Latin America Injectable Drug Delivery Market Attractiveness Analysis, By Usage

Figure 81: Latin America Injectable Drug Delivery Market Attractiveness Analysis, By Distribution Channel

Figure 82: APEJ Injectable Drug Delivery Market Size

Figure 83: APEJ Injectable Drug Delivery Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 84: India Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 85: India Ambulance Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 86: Australia & New Zealand Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 87: Australia & New Zealand Injectable Drug Delivery Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 88: China Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 89: China Ambulance Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 90: ASEAN Countries Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 91: ASEAN Countries Injectable Drug Delivery Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 92: Rest of APEJ Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 93: Rest of APEJ Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 94: APEJ Self-injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 95: APEJ Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 96: APEJ Needle-free Market Size (US$ Mn) Analysis, 2013–2017

Figure 97: APEJ Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 98: APEJ Autoinjectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 99: APEJ Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 100: APEJ Injectable Drug Delivery Market Attractiveness Analysis, By Country

Figure 101: APEJ Injectable Drug Delivery Market Attractiveness Analysis, By Product Type

Figure 102: APEJ Injectable Drug Delivery Market Attractiveness Analysis, By Usage

Figure 103: APEJ Injectable Drug Delivery Market Attractiveness Analysis, By Distribution Channel

Figure 104: Japan Injectable Drug Delivery Market Size

Figure 105: Japan Injectable Drug Delivery Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 106: Japan Self-injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 107: Japan Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 108: Japan Needle-free Market Size (US$ Mn) Analysis, 2013–2017

Figure 109: Japan Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 110: Japan Autoinjectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 111: Japan Autoinjectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 112: Japan Injectable Drug Delivery Market Attractiveness Analysis, By Product Type

Figure 113: Japan Injectable Drug Delivery Market Attractiveness Analysis, By Usage

Figure 114: Japan Injectable Drug Delivery Market Attractiveness Analysis, By Distribution Channel

Figure 115: MEA Injectable Drug Delivery Market Size

Figure 116: MEA Injectable Drug Delivery Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 117: GCC Countries Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 118: GCC Countries Ambulance Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 119: South Africa Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 120: South Africa Injectable Drug Delivery Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 121: Rest of MEA Injectable Drug Delivery Market Size (US$ Mn) Analysis, 2013–2017

Figure 122: Rest of MEA Injectable Drug Delivery Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 123: MEA Self-injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 124: MEA Self-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 125: MEA Needle-free Market Size (US$ Mn) Analysis, 2013–2017

Figure 126: MEA Needle-free Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 127: MEA Auto-injectors Market Size (US$ Mn) Analysis, 2013–2017

Figure 128: MEA Auto-injectors Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 129: MEA Injectable Drug Delivery Market Attractiveness Analysis, By Country

Figure 130: MEA Injectable Drug Delivery Market Attractiveness Analysis, By Product Type

Figure 131: MEA Injectable Drug Delivery Market Attractiveness Analysis, By Usage

Figure 132: MEA Injectable Drug Delivery Market Attractiveness Analysis, By Distribution Channel

Figure 133: Global Injectable Drug Delivery Market Attractiveness Analysis, By Region

Figure 134: Global Injectable Drug Delivery Market Attractiveness Analysis, By Product Type

Figure 135: Global Injectable Drug Delivery Market Attractiveness Analysis, By End User

Figure 136: Global Injectable Drug Delivery Market Attractiveness Analysis, By Distribution Channel

Figure 137: Global Single-Photon Emission Computed Tomography Historical Market Size and Y-o-Y, 2013 - 2017

Figure 138: Global Injectable Drug Delivery Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2028

Figure 139: Global Injectable Drug Delivery Market Absolute $ Opportunity, 2013–2028